These data provide new clues for targeting S100A4 in cancer treatment, indicating that in order to obtain an ideal inhibitory effect of S100A4 blockade on the malignancy of cancer cells, we should pay attention to its downstream counteracting mechanisms and try to correct them. This evidence concerns the gene S100A4 and cancer.